NCT02900456

Brief Summary

Intra-aortic Balloon Pumps (IABP) have been used for roughly 50 years in Critical Care Units, Intensive Care Units, Cath labs as a way to improve systemic and coronary circulation in patients in cardiogenic shock (CS) or at high risk situation as mechanical complications stemming from myocardial infarction (MI), critical coronary stenosis, high-risk PCI, etc. Several papers recently questioned the relevance of this assistance device - namely the IABP-SHOCK II trial in CS and the CRISP-AMI trial in anterior MI without CS - resulting in the downgrading of the recommendation standards of the IABP by medical societies.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
177

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2015

Typical duration for all trials

Geographic Reach
1 country

25 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2015

Completed
1.7 years until next milestone

First Submitted

Initial submission to the registry

August 26, 2016

Completed
19 days until next milestone

First Posted

Study publicly available on registry

September 14, 2016

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2017

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2018

Completed
Last Updated

November 14, 2017

Status Verified

November 1, 2017

Enrollment Period

2 years

First QC Date

August 26, 2016

Last Update Submit

November 13, 2017

Conditions

Keywords

Intra-aortic Balloon PumpsRegistry

Outcome Measures

Primary Outcomes (1)

  • IABP insertion rate

    1 year

Secondary Outcomes (6)

  • Number of cardiogenic shock

    1 year

  • Number of mechanical complication of acute coronary syndrome

    1 year

  • Number of myocardial infarction not shocked

    1 year

  • Number of other indications

    1 year

  • Survival rate following IABP insertion

    1 year

  • +1 more secondary outcomes

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Intra-aortic Balloon Pumps in patients in cardiogenic shock (CS) or at high risk situation as mechanical complications stemming from myocardial infarction (MI), critical coronary stenosis, high-risk PCI, etc

You may qualify if:

  • Males and females at least of 18 of age;
  • Undergoing IABP treatment ;
  • Subject, relatives or legal guardian signified their non-opposition to participate in the study

You may not qualify if:

  • \- IABP insertion in immediate post-intervention period

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (25)

CHU Angers

Angers, France

Location

Clinique Saint Joseph

Angers, France

Location

CHU Brest

Brest, France

Location

CHU Caen

Caen, France

Location

Hôpital Prive Saint Martin

Caen, France

Location

CH Chartres

Chartres, France

Location

CH Laval

Laval, France

Location

CH Le Mans

Le Mans, France

Location

CH Bretagne Sud

Lorient, France

Location

CHU Nantes

Nantes, France

Location

Nouvelles Cliniques Nantaises

Nantes, France

Location

CH Intercommunal de Cornouaille

Quimper, France

Location

CHU Rennes

Rennes, France

Location

Hôpital privé Beauregard

Rennes, France

Location

Polyclinique Saint-Laurent

Rennes, France

Location

CHU Rouen

Rouen, France

Location

Clinique Saint-Hilaire

Rouen, France

Location

CH Saint-Brieuc

Saint-Brieuc, France

Location

CH Saint-Nazaire

Saint-Nazaire, France

Location

Groupement Coopération Sanitaire Pui Cite Sanitaire

Saint-Nazaire, France

Location

Communauté Hospitalière de Territoire Rance Emeraude

St-Malo, France

Location

Polyclinique Les Fleurs

Toulon, France

Location

CHU Tours

Tours, France

Location

Clinique Saint Gatien

Tours, France

Location

CH Bretagne Atlantique

Vannes, France

Location

Study Officials

  • Guillaume LEURENT

    CHU Rennes

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
1 Year
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 26, 2016

First Posted

September 14, 2016

Study Start

January 1, 2015

Primary Completion

January 1, 2017

Study Completion

January 1, 2018

Last Updated

November 14, 2017

Record last verified: 2017-11

Data Sharing

IPD Sharing
Will not share

Locations